Logo
Give a Missed Call
+91 99532 12345
Logo
Give a Missed Call
+91 99532 12345
Login

Home

smallArrow

Stocks Screener

smallArrow

Marksans Pharma Share Price

Marksans Pharma Share Price

Marksans Pharma (INR)337.521.9   (7%)

Exchange ScripsBSE524404NSEMARKSANSISININE750C01026

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Marksans Pharma Performance

Market performance
Open price318.75
High344
Volumes10331352
Prev Close337.5
Low317.65
Closing date2024-11-26
Historical performance
1 Year High344.00
3 Year High344.00
5 Year High344.00
1 Year Low130.00
3 Year Low38.60
5 Year Low9.85

Marksans Pharma Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
15287
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
48.75
Dividend Yield
Dividend Yield
0.18 %

Marksans Pharma Investment Returns

1 Year
137.9%
3 Years
477.4%
5 Years
2195.9%
10 Years
480.4%

Marksans Pharma Technicals

IndicatorsValueSignal
5-DMA315.24Bullish
10-DMA308.86Bullish
20-DMA298.54Bullish
50-DMA293.41Bullish
100-DMA253.07Bullish
200-DMA205.59Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters22222
Foreign Investors---------------
Domestic Investors22222
Public Investors248843235498254697237375207935
Government---------------

Marksans Pharma Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income50459341967
Operating Profit5090398630073463
Interest112918480
Depreciation743519448362
Profit Before Tax4235337724753022
Consolidated Net Profit3137266318462359
Adjusted EPS7656

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital453453409409
Total Reserves2019716998106828456
Minority Interest209199207189
Total Non-Current Liabilities2052843571237
Total Liabilities26810219041660112280
Capital Work in Progress5472756
Total Assets26810219041660112280

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities230423749931786
Cash Flow from Investing Activities-1408-2592-844-448
Cash Flow from Financing Activitie-6871978795-153
Net Cash Inflow / Outflow20817609441185
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 48.75.
  • 3Y Stock Price CAGR of the stock is 81.4.
  • The stock has a beta of 1.0.
  • In the last financial year, the company had an EBITDA of ₹5090 Million.
  • The company generated revenue of ₹21774 Million in the previous financial year.

Marksans Pharma

337.521.9   (7%)

Investment Amount: ₹ 14270
Current Value: ₹ 33750
Performence: 136.5%
P/L: ₹ 19480
Top Gainers
SymbolChange%
TOLINS211.89(20%)
KREBSBIO117.34(20%)
RPPINFRA199.51(20%)
3PLAND66.7(20%)
RUBYMILLS248.96(20%)
Top Losers
SymbolChange%
DIL5.76(-20%)
NEXTMEDIA10.46(-10%)
POLYMED2763.9(-8%)
CENTUM1495.3(-8%)
ADANIGREEN898.55(-7%)
APCOTEXIND366.2(-6%)
BSE4431.1(-6%)
KRN742.7(-5%)
Similar stocks

Vimta Labs

▲ 60.6

896.55

October 26 - November 26

Jagsonpal Pharma

▲ 54.3

696.2

October 26 - November 26

Krebs Biochem.&Inds

▲ 52.2

117.34

October 26 - November 26

Panacea Biotec

▲ 49.5

422.95

October 26 - November 26

Innova Captab

▲ 46.7

1041.9

October 26 - November 26

Supriya Lifescience

▲ 45.2

794.9

October 26 - November 26

AMI Organics

▲ 42.3

2147.5

October 26 - November 26

Dishman Carbogen Amc

▲ 37

237.98

October 26 - November 26

Announcing Stock of the Month!

Stock of the Month
Stock of the Month